Brodalumab to the Rescue: Efficacy and Safety of Brodalumab in Patients with Psoriasis and Prior Exposure or Inadequate Response to Biologics
Abstract While biologic therapies for psoriasis are effective for many patients, some patients may lose response, have inadequate control of disease, or develop intolerance to certain biologic agents. It may therefore be beneficial for patients whose psoriasis fails to respond to one biologic to swi...
Saved in:
Main Authors: | Alan Menter (Author), April Armstrong (Author), Abby Van Voorhees (Author), Clive Liu (Author), Abby Jacobson (Author) |
---|---|
Format: | Book |
Published: |
Adis, Springer Healthcare,
2020-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of Brodalumab in Patients with Psoriasis and Risk Factors for Treatment Failure: A Review of Post Hoc Analyses
by: Mark G. Lebwohl, et al.
Published: (2024) -
Brodalumab: 5-Year US Pharmacovigilance Report
by: Mark G. Lebwohl, et al.
Published: (2024) -
Brodalumab
by: Murat Borlu
Published: (2022) -
Brodalumab in psoriasis: evidence to date and clinical potential
by: Amy C Foulkes, et al.
Published: (2019) -
Spotlight on brodalumab in the treatment of plaque psoriasis: the evidence to date
by: Galluzzo M, et al.
Published: (2019)